ORIGINAL ARTICLE
Year : 2022 | Volume
: 14 | Issue : 2 | Page : 55--59
Chronic liver disease in HIV patients: Determinants and clinical manifestations
Sarah Tonye Abere1, Boma Oyan2, Blessing Azukoye-Amadi1, Enohor Edna Amachree1
1 Gastroenterology Unit, Department of Internal Medicine, Rivers State University Teaching Hospital, Port Harcourt, Nigeria
2 Cardiology Unit, Department of Internal Medicine, Rivers State University Teaching Hospital, Port Harcourt, Nigeria
Correspondence Address:
Sarah Tonye Abere
Gastroeneterology Unit, Department of Internal Medicine, Rivers State University Teaching Hospital, Port Harcourt
Nigeria
Background and Aim: Chronic liver disease (CLD) is a common cause of morbidity and mortality in medical wards of tertiary hospitals in Nigeria, and the etiology varies from viral hepatitis B and C, retroviral disease, alcoholic and non-alcoholic fatty liver disease, drug toxicity to several other causes. Liver diseases have also been recognized as a leading cause of death among HIV-infected persons. We aim to elucidate the pattern of clinical presentation of CLD in non-hepatitis B virus/hepatitis C virus patients who are HIV-seropositive with minimal alcohol consumption as well as to identify the prevalence and risk factors for CLD in the subjects. Materials and Methods: This was a retrospectively analyzed case–control study of 170 HIV-seropositive patients with age- and sex-matched controls seen at the medical outpatient department and wards of the University of Port Harcourt Teaching Hospital. Sociodemographic, anthropometric, clinical, and laboratory characteristics were extracted and were analyzed with SPSS version 21. Results: Sixty-three (37.1%) HIV patients had clinical manifestations of CLD with fatigue (51, 30%) and hepatomegaly (14, 8.2%) as the commonest symptom and sign, respectively. Chronic use of medications including highly active antiretroviral therapy (5.1 ± 1.6 years, P = 0.000) and herbal preparations (n = 20, 11.8%, P = 0.000) were the most significant determinants of CLD. Hypoalbuminemia and low CD4 counts were observed. Conclusion: CLD is common in HIV patients without viral hepatitis B and C. Early identification of risk factors and proper clinical evaluation can aid in its mitigation.
How to cite this article:
Abere ST, Oyan B, Azukoye-Amadi B, Amachree EE. Chronic liver disease in HIV patients: Determinants and clinical manifestations.Niger J Gastroenterol Hepatol 2022;14:55-59
|
How to cite this URL:
Abere ST, Oyan B, Azukoye-Amadi B, Amachree EE. Chronic liver disease in HIV patients: Determinants and clinical manifestations. Niger J Gastroenterol Hepatol [serial online] 2022 [cited 2023 Mar 23 ];14:55-59
Available from: https://www.njghonweb.org/article.asp?issn=2251-0079;year=2022;volume=14;issue=2;spage=55;epage=59;aulast=Abere;type=0 |
|
|
|
